Full List arrival Synergy Healthcare says first-quarter sales were 30 per cent ahead, with new contracts swelling the order book.

Derby-based Synergy moved from AIM to the main market on Monday and provides sterilisation and control services to healthcare concerns at home and abroad. The company, which increased pre-tax profits 115 per cent to £18.9 million in the year to March, says services under the Central Lancashire Decontamination Scheme will start this autumn, while four new sterilisation contracts will add £3.4 million over four years to an £800 million forward order book, around £140 million of it scheduled for next year.

UBS analysts see pre-tax profits rising 44.3 per cent to £27.2 million in 2008/09 on turnover up 20 per cent to £270 million. Synergy shares, which surged from 402.5p to 898p between 2005 and a year ago, now stand at 737.5p, up 44.5p today, valuing the company at £393 million.    

Growth Company Investor is the UK’s leading authority on small-cap and AIM companies. You can gain immediate access to all the recent share recommendations with no obligation, with a free 30-day trial. Click here to join today.

Synergy Healthcare	LSE	£221.44m	411.25p	0.00p
Click here for interactive charting
Other company articles:
Synergy maintains growth			09/07/2008
Synergy Healthcare			10/06/2008
Synergy sees 'strong momentum'			20/11/2007
Fund Manager Focus by Pauline McCallion			09/08/2007
GCI grabs research gong			06/11/2006